Sabra Healthcare REIT Given New $30.00 Price Target at Raymond James (SBRA)
Raymond James lifted their price target on shares of Sabra Healthcare REIT (NASDAQ:SBRA) from $27.00 to $30.00 in a research note issued on Friday, StockRatingsNetwork.com reports. Raymond James’ price objective indicates a potential upside of 11.52% from the company’s current price.
Sabra Healthcare REIT (NASDAQ:SBRA) remained flat at $26.90 during trading on Friday. The stock had a trading volume of 340,941 shares. Sabra Healthcare REIT has a one year low of $19.54 and a one year high of $32.40. The stock’s 50-day moving average is $24.36 and its 200-day moving average is $26.26. The company has a market cap of $1.004 billion and a P/E ratio of 52.75.
Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, October 23rd. The company reported $0.46 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.46. The company had revenue of $32.90 million for the quarter, compared to the consensus estimate of $33.01 million. On average, analysts predict that Sabra Healthcare REIT will post $1.86 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, November 29th. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 5.06%. The ex-dividend date of this dividend is Wednesday, November 13th.
A number of other analysts have also recently weighed in on SBRA. Analysts at Zacks upgraded shares of Sabra Healthcare REIT from a “neutral” rating to an “outperform” rating in a research note to investors on Monday. They now have a $28.60 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Sabra Healthcare REIT from $28.00 to $30.00 in a research note to investors on Friday, October 25th. They now have a “buy” rating on the stock. Finally, analysts at Jefferies Group upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a research note to investors on Wednesday, September 18th. They now have a $26.00 price target on the stock, down previously from $27.00. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Sabra Healthcare REIT presently has a consensus rating of “Buy” and a consensus target price of $30.32.
Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.